A prospective study suggested that in colorectal cancer patients, prediagnostic plasma adiponectin was associated with an increased risk of colorectal cancer-specific and overall mortality, and was more obvious in those with metastatic disease [20]. The gene discussed is ADIPOQ; the disease is metastatic neoplasm.